Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Richard Wolf GmbH is a leading global manufacturer of medical technology devices and systems, particularly in endoscopy, minimally invasive surgery, extracorporeal shock wave therapies, and specialized imaging for urology, gynecology, general surgery, orthopedics, pulmonology, spine surgery, proctology, and pediatrics. The company is known for its integrated operating room systems, advanced camera platforms (e.g., ENDOCAM Logic HD, ENDOCAM Logic 4K), and innovative disposable and reusable endoscopic instruments. Richard Wolf has pioneered products such as the eyeMAX chip-on-the-tip laparoscope, ERAGONbipolar and ERAGONmodular instrument systems, the COBRA dual-channel laser ureterorenoscope, and the PiezoWave 2/PiezoLith 3000plus shock wave systems. Its technology portfolio reflects ongoing innovation, with recent launches including System blue/System green for real-time fluorescence imaging and Secufix Uterus Manipulator for laparoscopic hysterectomy[1]. The company maintains a broad global presence with 18 subsidiaries, over 130 distribution partners, and 1,700 employees[4][6].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Richard & Wolf.